Clinical Trials Directory

Trials / Terminated

TerminatedNCT01502748

Endovascular Magnesium Sampling in Acute Stroke

Magnesium Therapy: a Novel Platform for Neuroprotectant Sampling in Acute Stroke

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
2 (actual)
Sponsor
University of Southern California · Academic / Other
Sex
All
Age
40 Years – 95 Years
Healthy volunteers
Not accepted

Summary

This investigation will address the safety and feasibility of distal, intra-arterial sampling through endovascular access, in acute stroke patients. Levels of Magnesium will be measured in the region of infarct in patients who had been treated with intravenous Magnesium therapy following an acute stroke. This study attempts to address whether the traditional intravenous means of neuroprotectant administration achieves adequate concentration of the therapeutic agent in the area of diseased tissue.

Conditions

Interventions

TypeNameDescription
OTHERendovascular samplingPaired sampling from the distal arterial(endovascular catheter) and peripheral venous (femoral sheath) locations: withdrawal of 3ml of blood from vasculature distal to the occlusive thrombus

Timeline

Start date
2012-03-01
Primary completion
2013-02-01
Completion
2013-02-01
First posted
2012-01-02
Last updated
2017-08-01

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01502748. Inclusion in this directory is not an endorsement.

Endovascular Magnesium Sampling in Acute Stroke (NCT01502748) · Clinical Trials Directory